GLP-1 drugs have long-term benefit for heart health
New study found weight-loss medications reduced cardiovascular events by 13%
Read our latest stories
-
11 May 2026
-
1 May 2026 
School of Medicine is advancing opportunities
ARU is aiming to ease Essex’s workforce issues by levelling the playing field
-
30 April 2026 
ARU student nurses receive national recognition
Tonicha Patterson and Oreoluwa Akinwunmi win Student Nursing Times Awards
-
28 April 2026 
‘Eye stroke’ has been linked to weight loss injections
VIEWPOINT: Rare side effect can cause sudden vision loss.
-
23 April 2026 
Weight-loss drugs could tackle Alzheimer’s – study
New review shows comprehensive evidence of impact of GLP-1 receptor agonists
-
22 April 2026 
Trial shows relief for those living with chronic angina
New study found angioplasty with stenting yielded significant boost to quality of life
-
20 March 2026 
Can listening to 'pink noise' make your sleep worse?
VIEWPOINT: 50% of people in the UK listen to some kind of noise to help fall asleep
-
19 March 2026 
Data suggests a million UK adults spiked in last year
Latest UK drink spiking survey to be presented at ARU during the Cambridge Festival
-
18 March 2026
What is 'eye stroke' and the link to weight-loss injections?
VIEWPOINT: Phrase has recently appeared about very rare side effect
-
2 March 2026 
How to survive the ‘ultimate medical event’
Cardiologist Dr Thomas Keeble will discuss survival and recovery from cardiac arrest